Consolidated Condensed Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Operating activities:
Net loss	$ (9,647)	$ (7,407)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	730	772
Share-based compensation	2,791	2,047
Changes in operating assets and liabilities:
Accounts receivable	1,495	22
Accounts receivable pledged as collateral	0	1,313
Inventories	(1,012)	483
Accounts payable and accrued liabilities	553	(2,562)
Accrued payroll and employee compensation	(143)	(170)
Other assets and liabilities, net	(121)	1,393
Net cash used in operating activities	(5,354)	(4,109)
Investing activities:
Purchase of fixed assets	(352)	(203)
Purchase of intangible assets	0	(150)
Net cash used in investing activities	(352)	(353)
Financing activities:
Proceeds from issuance of common stock, net of issuance costs	0	3,991
Payment for restricted stock units tax liability on net settlement	(431)	0
Proceeds from exercise of outstanding warrants	138	0
Proceeds from exercise of stock options and ESPP purchases	59	15
Proceeds from borrowings	3,500	0
Repayment of accounts receivable pledged as collateral, net	0	(919)
Repayment of principal on long-term debt	0	(693)
Net cash provided by (used in) financing activities	3,266	2,394
Effect of exchange rate changes on cash	(17)	13
Net decrease in cash and cash equivalents	(2,457)	(2,055)
Cash and cash equivalents, beginning of period	10,168	8,852
Cash and cash equivalents, end of period	7,711	6,797
Non-cash activities — Equity award fair value adjustment to liability	$ (213)	$ 0